The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125483631 12548363 1 I 20160705 20160712 20160712 EXP US-009507513-1607USA002517 MERCK 0.00 Y 0.00000 20160712 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125483631 12548363 1 PS TEMODAR TEMOZOLOMIDE 1 U 21029 CAPSULE
125483631 12548363 2 SS BEVACIZUMAB BEVACIZUMAB 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125483631 12548363 1 Glioblastoma
125483631 12548363 2 Glioblastoma

Outcome of event

Event ID CASEID OUTC COD
125483631 12548363 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125483631 12548363 Anaemia
125483631 12548363 Arthralgia
125483631 12548363 Blindness transient
125483631 12548363 Constipation
125483631 12548363 Cough
125483631 12548363 Decreased appetite
125483631 12548363 Dental caries
125483631 12548363 Dizziness
125483631 12548363 Ear discomfort
125483631 12548363 Fatigue
125483631 12548363 Flatulence
125483631 12548363 Headache
125483631 12548363 Hyperglycaemia
125483631 12548363 Hyperhidrosis
125483631 12548363 Hypertension
125483631 12548363 Hypokalaemia
125483631 12548363 Hyponatraemia
125483631 12548363 Lymphocyte count decreased
125483631 12548363 Memory impairment
125483631 12548363 Myalgia
125483631 12548363 Nausea
125483631 12548363 Pain in extremity
125483631 12548363 Pollakiuria
125483631 12548363 Proteinuria
125483631 12548363 Pyramidal tract syndrome
125483631 12548363 Pyrexia
125483631 12548363 Seizure
125483631 12548363 Stomatitis
125483631 12548363 Upper-airway cough syndrome
125483631 12548363 Vomiting
125483631 12548363 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found